CD38 and primary cutaneous T-cell non-Hodgkin lymphoma: This review comprehensively summarizes the expression patterns of CD39, CD73, and CD38 in CTCL (Figure 3), providing new insights for the diagnosis, prognosis, and treatment of aggressive CTCL including SS.